Figure 4

Assessment of efficacy at the end of the treatment by investigators and patients (per protocol population, n = 133). (A = investigators, B = patients).
Assessment of efficacy at the end of the treatment by investigators and patients (per protocol population, n = 133). (A = investigators, B = patients).